Apollomics, Inc.

NASDAQ:APLM

Biotechnology

Healthcare
$17.84 +34.72%

+$6.03 today

Market cap
$52.00M
Beta
1.45
P/E (TTM)
-3.1
EPS (TTM)
-$25.98
52W Low $3.66High $42.12

Volume 0.02M

Average 0.02M

Returns on capital

Apollomics, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

343.1%

avg -135.8%

ROIC

-1586.8%

avg -369.5%

ROA

-162.9%

avg -197.1%

Analysis

ROE is currently the strongest return metric at 343.1% versus its period average of -135.8%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Hung-Wen Chen

Chief Executive Officer & Chairman of the Board—655.00K0.23%

Yi-Kuei Chen

Director & Chief Operating Officer—565.00K0.23%

K. H. Lin

Chief Financial Officer—56——

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 15, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

5

$8.25M

Sells

0

$0.00

Net Transaction Value

+$8.25M

Net buying

Most Active

Chen Hung-Wen

3 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Aug 14, 26

Chen Yi-Kuei

Indirect

Buy$300K
Aug 14, 26

LIN PETER KUAN-HOW

Direct

Buy$400K
Aug 14, 26

Chen Hung-Wen

Indirect

Buy$4M
Aug 14, 26

Chen Hung-Wen

Direct

Buy$1.5M
Aug 14, 26

Chen Hung-Wen

Direct

Buy$2M

Summary

Insiders reported 5 buys worth $8.25M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $8.25M. Chen Hung-Wen was the most active insider with 3 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A+197.4%
+14.6% (3yr)1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Recent growth has been strongest in Revenue at +197.4% over three years. Forward estimates point to Revenue at +14.6% (3yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Apollomics, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Competitors

Peer companies in the same sector

Health

Questions

Management questions

Common questions about APLM's management, answered from reported figures.

Who manages APLM?

Apollomics, Inc. (APLM) lists 3 active executives. The top listed executive is Hung-Wen Chen, Chief Executive Officer & Chairman of the Board.

Are APLM insiders buying or selling?

Recent insider activity shows net buying of $9.05M.